ranjita shegokar

Ranjita Shegokar Ph.D

Ranjita Shegokar holds a Ph.D. degree in Pharmaceutical Technology from the SNDT University, India, and has been a postdoctoral researcher in the Department of Pharmaceutics, Biopharmaceutics and NutriCosmetics at the Free University of Berlin, Germany. For the last many years she has been working with various multinational pharmaceutical companies in technical/R&D leadership roles. Currently, she serves as Chief Scientific Officer (CSO) at Capnopharm GmbH, Germany. She has authored several research articles, book chapters, and presented her research in many national/international conferences. She has filed multiple patent applications in the area of drug delivery and targeting. Besides that, she has edited many trending books in the area of pharmaceutical nanotechnology and drug delivery aspects. For her research, she has received many prestigious national and international awards among them include recently received prestigious German Innovation Award 2022. Her areas of interest include polymeric nanoparticles, nanocrystals, lipid nanoparticles (SLNs/NLCs), nanoemulsions, cancer drug targeting and the role of excipients in delivery systems.

Ranjita Shegokar Ph.D


ranjita shegokar
Ranjita Shegokar holds a Ph.D. degree in Pharmaceutical Technology from the SNDT University, India, and has been a postdoctoral researcher in the Department of Pharmaceutics, Biopharmaceutics and NutriCosmetics at the Free University of Berlin, Germany. For the last many years she has been working with various multinational pharmaceutical companies in technical/R&D leadership roles. Currently, she serves as Chief Scientific Officer (CSO) at Capnopharm GmbH, Germany. She has authored several research articles, book chapters, and presented her research in many national/international conferences. She has filed multiple patent applications in the area of drug delivery and targeting. Besides that, she has edited many trending books in the area of pharmaceutical nanotechnology and drug delivery aspects. For her research, she has received many prestigious national and international awards among them include recently received prestigious German Innovation Award 2022. Her areas of interest include polymeric nanoparticles, nanocrystals, lipid nanoparticles (SLNs/NLCs), nanoemulsions, cancer drug targeting and the role of excipients in delivery systems.
Master's – Pharm Tech Immediate release pediatric suppositories Post-Doc. – Pharm Nanotech Dermal and mucosal drug targeting : Nanoparticles DFE Pharma GmbH & Co. KG Oral Solid Dosage Forms (OSDFs) Capnomed GmbH Drug Targeting – conventional/nano/micro
      PhD – Pharm Nanotech Drug Targeting to splenic HIV reservoirs : Nanoparticle PharmaSol GmbH Nanocrystals- industrial production Symrise AG Immediate and controlled active release (Conventional/nano/micro)  
Master's – Pharm Tech Immediate release pediatric suppositories PhD – Pharm Nanotech Drug Targeting to splenic HIV reservoirs : Nanoparticle Post-Doc. – Pharm Nanotech Dermal and mucosal drug targeting : Nanoparticles PharmaSol GmbH Nanocrystals- industrial production DFE Pharma GmbH & Co. KG Oral Solid Dosage Forms (OSDFs) Symrise AG Immediate and controlled active release (Conventional/nano/micro) Capnomed GmbH Drug Targeting – conventional/nano/micro
Solid lipid nanoparticles (SLNs) have gained momentum over the three decades due to its role in... Read more
Drug nanocrystals are a formulation principle for systemic and also, intracellular delivery of... Read more
Coenzyme Q10 (CoQ10) is a promising candidate in the pharmaceutical and nutraceutical field... Read more
Unique properties of graphene are attracting great attention of scientists for various biomedical... Read more
Lipid nanoparticles especially SLNs and NLCs are well trusted and long researched (almost 25... Read more
RNAi therapeutics, has quickly been established as a robust and effective gene silencing strategy... Read more